文献速递肺外科

非小细胞肺癌术后骨骼肌减少对预后的影响

Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.
PubMed 文献 · Ann Thorac Surg · 2019-10-23

该研究纳入204例接受根治性肺切除且术前及术后1年CT影像可用的非小细胞肺癌患者,以第12胸椎水平骨骼肌面积计算术后/术前比值,界值设为0.9。结果显示34.3%患者术后骨骼肌减少,该状态为总生存和无病生存的独立不良预后因素,并与术后营养炎症指标恶化显著相关。

要点

  • 术后骨骼肌减少(比值<0.9)占34.3%,与低BMI显著相关。
  • 术后骨骼肌减少是总生存和无病生存的独立不良预后因素。
  • 术后骨骼肌减少与营养炎症指标恶化显著相关,需关注营养干预。

核心结论

  • 非小细胞肺癌术后骨骼肌减少与术后不良结局显著相关。
  • 需进一步研究术后营养干预的临床影响。

研究设计与样本

  • 回顾性分析204例接受根治性肺切除且术前及术后1年CT影像可用的NSCLC患者。
  • 采用第12胸椎水平骨骼肌面积,术后/术前比值界值为0.9。

主要发现

  • 70例(34.3%)患者归为骨骼肌减少组。
  • 低体重指数与骨骼肌减少显著相关(P = .019)。
  • 骨骼肌减少是总生存不良的独立预后因素(P < .001)。
  • 骨骼肌减少是无病生存不良的独立预后因素(P = .001)。
  • 骨骼肌减少与术后中性粒细胞-淋巴细胞比值恶化显著相关(P = .009)。

关键数值与推荐

  • 骨骼肌减少定义为术后/术前 normalized SMA 比值<0.9。
  • 骨骼肌减少与血小板-淋巴细胞比值恶化显著相关(P = .026)。
  • 骨骼肌减少与改良格拉斯哥预后评分恶化显著相关(P = .003)。
  • 骨骼肌减少与预后营养指数恶化显著相关(P = .013)。

临床怎么用

  • 术后应关注骨骼肌面积变化,比值<0.9提示不良预后风险。
  • 对骨骼肌减少患者可考虑营养状态评估与干预。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preoperative skeletal muscle loss was reported to be associated with a postoperative poor prognosis in non-small cell lung cancer (NSCLC) patients. The aim of this study was to elucidate the relationship between the change in skeletal muscle mass after surgery and the postoperative outcomes in NSCLC patients. METHODS: The data were analyzed for 204 NSCLC patients who had undergone curative lung resection and whose preoperative and postoperative (1-year) computed tomographic images were available. The skeletal muscle area (SMA) at the 12th thoracic vertebra level was used. Postoperative/preoperative ratio was defined as postoperative normalized SMA (cm2/m2) divided by preoperative normalized SMA. The cutoff value was set to a postoperative/preoperative ratio of 0.9. The neutrophil-lymphocyte ratio, the platelet-lymphocyte ratio, modified Glasgow prognostic score, and prognostic nutritional index were used to estimate change in the nutritional status. RESULTS: There were 70 patients (34.3%) classified into the SMA-decreased group. Low body mass index was significantly associated with the SMA-decreased patients (P = .019). The SMA-decreased status was an independent prognostic factor for poor overall survival (P < .001) and disease-free survival (P = .001). The SMA-decreased status was significantly associated with the postoperative exacerbation of the neutrophil-lymphocyte ratio (P = .009), platelet-lymphocyte ratio (P = .026), modified Glasgow prognostic score (P = .003), and prognostic nutritional index (P = .013). CONCLUSIONS: Skeletal muscle loss after surgery is significantly associated with poor postoperative outcomes in NSCLC patients. Further studies investigating the clinical impact of postoperative nutritional intervention are needed.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Takamori S, Tagawa T, Toyokawa G, et al. Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer. Ann Thorac Surg. 2019. PMID: 31655044. doi:10.1016/j.athoracsur.2019.09.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。